Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2015 08:00 ET | Source: Auris Medical AG

Auris Medical Announces Enrolment of First Patient in HEALOS Study of AM-111 in Treatment of Idiopathic Sudden Sensorineural Hearing Loss

Zug, Switzerland, November 13, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
November 12, 2015 06:05 ET | Source: Auris Medical AG

Auris Medical AG : Auris Medical Holding AG Reports Third Quarter 2015 Financial Results and Provides Business Update

ZUG, Switzerland, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (NASDAQ: EARS) today provided an update on the Company's business and announced financial results for the third quarter...
November 12, 2015 06:00 ET | Source: Auris Medical AG

Auris Medical AG : Auris Medical Holding AG Reports Third Quarter 2015 Financial Results and Provides Business Update

Auris Medical News Release Auris Medical Holding AG Reports Third Quarter 2015 Financial Results and Provides Business Update Zug, Switzerland, November 12, 2015 - Auris Medical Holding...
November 05, 2015 07:38 ET | Source: Auris Medical AG

Auris Medical to Announce Third Quarter 2015 Financial Results and Host Conference Call on Thursday, November 12, 2015

Zug, Switzerland, November 5, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important medical needs in otolaryngology,...
October 23, 2015 08:00 ET | Source: Auris Medical AG

Auris Medical and King's College London Collaborate in Drug Discovery for Second Generation Tinnitus Treatment

Zug, Switzerland, October 23, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
September 25, 2015 06:00 ET | Source: Auris Medical AG

Auris Medical to Host Corporate Symposium on Rational Pharmacotherapy for Acute Hearing Loss on September 28, 2015

Zug, Switzerland, September 25, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
September 23, 2015 06:00 ET | Source: Auris Medical AG

Auris Medical to Present at the Leerink Partners 4th Annual Rare Disease Roundtable on Wednesday, September 30, 2015

Zug, Switzerland, September 23, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
August 19, 2015 06:00 ET | Source: Auris Medical AG

Auris Medical Holding AG Reports Second Quarter 2015 Financial Results and Provides Business Update

Zug, Switzerland, August 19, 2015 - Auris Medical Holding AG (NASDAQ: EARS) today provided an update on the Company's business and announced financial results for the second quarter ended June 30,...
August 12, 2015 06:00 ET | Source: Auris Medical AG

Auris Medical to Announce Second Quarter 2015 Financial Results and Host Conference Call on Wednesday, August 19, 2015

Zug, Switzerland, August 12, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important medical needs in otolaryngology,...
August 03, 2015 08:00 ET | Source: Auris Medical AG

Auris Medical Promotes Anne Sabine Zoller to General Counsel

Zug, Switzerland, August 3, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...